Disorder outline PML accompanied multiplexity is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multiplexing. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological disorders that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for effectiveness and adverse reactions, adapted to timely schemes depending on the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of polycystic PML. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.